Work

Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy, Pharmacodynamics, and Immunogenicity in AChR+ Cohort (Week 52) (S14.009)

Year: 2026

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000216387

Authors: Kristen Clarkson, Kimiaki Utsugisawa, Michael Benatar, Emma Ciafaloni, Maria Leite, John Vissing, Fengming Tang, Cody J. Peer, Sue Cheng, James Howard, Richard Nowak

Institutions: Amgen (United States), General Hanamaki Hospital, University of Miami, University of Rochester Medicine, University of Oxford, University of Copenhagen, University of North Carolina at Chapel Hill, Yale University

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7164199808

FWCI:

Cites:

Cited by:

Related to: